EUVIMEDEUVIMED entdecken
Open Access

Treatment of Presumptive Rejection After Orthotopic Pig‐to‐Baboon Cardiac Xenotransplantation

Chace B Mitchell, Sarah J Neal, Joe H Simmons, Sriram Chitta, David K C Cooper, David C Cleveland, John D Cleveland

Xenotransplantation · 2025

DOI: 10.1111/xen.70044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Xenotransplantation, 2025. Verfasst von Chace B Mitchell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic Surgery, Department of Surgery, Heart Institute, Children's Hospital of Los Angeles (CHLA), University of Southern Califor…. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Graft Rejection, Heart Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NHLBI NIH HHS, eGenesis Biotechnology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Significant progress has been made in the long‐term survival of non‐human primates after orthotopic gene‐edited pig cardiac xenotransplantation. However, to our knowledge, there are no reports of the successful reversal of an acute rejection episode in such an experiment. We present evidence suggesting that rejection can be reversed with corticosteroids and complement inhibition.

Methods

Orthotopic transplantation of a pig heart (with 69 gene‐edits) was carried out in a baboon. The immunosuppressive regimen was based on CD40/CD154 T cell co‐stimulation pathway blockade and rapamycin. Cardiac function remained excellent until Day 162, when there were increases in heart rate, ventricular septal wall thickness, left ventricular end‐diastolic pressures (LVEDP), and troponin level, which were associated with a low serum level of rapamycin (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplantation, HeterologousGraft RejectionHeart TransplantationAnimalsSwineImmunosuppressive AgentsPapioHeterograftsSirolimusGraft Survival

Stichwörter der Autor:innen

cardiac xenotransplantationgenetically modified xenograftpediatricrejection

Substanzen

Immunosuppressive AgentsSirolimus

Autor:innen und Institutionen

  • Division of Cardiothoracic Surgery, Department of Surgery, Heart Institute, Children's Hospital of Los Angeles (CHLA), University of Southern California (USC), Los Angeles, California, USA.
  • Department of Comparative Medicine, The University of Texas MD Anderson Cancer Center, Michale E. Keeling Center for Comparative Medicine and Research, Bastrop, Texas, USA.
  • Center for Transplantation Sciences, Massachusetts General Hospital / Harvard Medical School, Boston, Massachusetts, USA.

Förderung

  • NIH HHS
  • NHLBI NIH HHS
  • eGenesis Biotechnology
  • National Institutes of Health

Zitieren

APA

Mitchell, C. B., Neal, S. J., Simmons, J. H., Chitta, S., Cooper, D. K. C., Cleveland, D. C., & Cleveland, J. D. (2025). Treatment of Presumptive Rejection After Orthotopic Pig‐to‐Baboon Cardiac Xenotransplantation. Xenotransplantation. https://doi.org/10.1111/xen.70044

Vancouver

Mitchell CB, Neal SJ, Simmons JH, Chitta S, Cooper DKC, Cleveland DC, et al. Treatment of Presumptive Rejection After Orthotopic Pig‐to‐Baboon Cardiac Xenotransplantation. Xenotransplantation. 2025. doi:10.1111/xen.70044

BibTeX
@article{Mitchell2025,
  author = {Mitchell, Chace B and Neal, Sarah J and Simmons, Joe H and Chitta, Sriram and Cooper, David K C and Cleveland, David C and Cleveland, John D},
  title = {Treatment of Presumptive Rejection After Orthotopic Pig‐to‐Baboon Cardiac Xenotransplantation},
  journal = {Xenotransplantation},
  year = {2025},
  doi = {10.1111/xen.70044}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche